FDA.reportPublic FDA data

lumicain Topical Hemostatic Solution

Manufacturer
Medical Products Laboratories, Inc.
Effective date
2020-12-23
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 20:34:19

Label at a glance#

Productlumicain
Active ingredientALUMINUM CHLORIDE
Label structure3 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

FOR TOPICAL APPLICATION ONLY

For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.

If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.

WARNINGS AND PRECAUTIONS SECTION

CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

lbllblpremier lumicain TM Topical Hemostatic Solution 60cc

For Rapid Control of Minor Hemorrhage

Each Gram Contains: Aluminium Chloride............250 mg.

In an aqueous base.

Enter section text here

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
244613aluminum chloride 25 % Topical SolutionPSN4
486109lumicain 25 % Topical SolutionPSN4
486109aluminum chloride 250 MG/ML Topical Solution [Lumicain]SBD4
244613aluminum chloride 250 MG/ML Topical SolutionSCD4
244613aluminum chloride 25 % Topical SolutionSY4
486109Lumicain 25 % Topical SolutionSY4
486109Lumicain 250 MG/ML Topical SolutionSY4

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10733-412-602020-12-23C16284748780-1960f7f55-d9b2-8e05-e053-dbdaa90a074alumicain Topical Hemostatic Solution
10733-412-602019-10-29C16284748780-1960f7f55-d9b2-8e05-e053-dbdaa90a074alumicain Topical Hemostatic Solution

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10733-412-60lumicain67 g in 1 BOTTLESOLUTION674

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10733-412LUMICAIN (ALUMINIUM CHLORIDE HEXAHYDRATE) SOLUTION [MEDICAL PRODUCTS LABORATORIES, INC.]4Current NDC, Legacy NDC, 1 package rows20201224_9fdcce3e-e4d4-41ae-8609-37987c12414e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10733-412-60ML - Milliliter10733-412002f89ea-d6e2-45a4-956e-87539810e1c112025-12-16

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ALUMINUM CHLORIDEACTIVE INGREDIENT3CYT62D3GA1
ALUMINUMACTIVE MOIETYCPD4NFA9031
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10733-41210733-412-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
ALUMINUM CHLORIDE3CYT62D3GAACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
lumicainALUMINIUM CHLORIDE HEXAHYDRATEMedical Products Laboratories, Inc.9fdcce3e-e4d4-41ae-8609-37987c12414e2020-12-23WarningsExact identifier
ndc (package): 10733-412-60
ndc (product): 10733-412
ndc11 (package): 10733041260
spl id: b725dd26-c793-51a4-e053-2a95a90a573d
spl set id: 9fdcce3e-e4d4-41ae-8609-37987c12414e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.